UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

(239) Bioequivalence of abuse-deterrent, immediate-release (ADIR) oxycodone compared with IR oxycodone without abuse-deterrent properties

The journal of pain, 2017-04, Vol.18 (4), p.S35-S36

2017

Volltextzugriff (PDF)

(430) Bioequivalence and food effect of a novel, abuse-deterrent (AD), extended-release (ER) morphine product candidate compared with a currently available non-AD, ER morphine product

The journal of pain, 2016-04, Vol.17 (4), p.S82-S82

2016

Volltextzugriff (PDF)

(237) Novel design to evaluate the efficacy and safety of an abuse-deterrent, extended-release oxycodone product candidate in patients with moderate-to-severe chronic low back pain

The journal of pain, 2017-04, Vol.18 (4), p.S35-S35

2017

Volltextzugriff (PDF)

(238) The relationship between the pharmacokinetics of morphine abuse-deterrent, extended-release, injection-molded tablets and pharmacodynamic outcomes in oral and intranasal human abuse potential studies

The journal of pain, 2017-04, Vol.18 (4), p.S35-S35

2017

Volltextzugriff (PDF)

Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome

Respiratory medicine, 2007-03, Vol.101 (3), p.616-627

2007

Volltextzugriff (PDF)

Efficacy and tolerability of hydrocodone extended-release tablets for the treatment of moderate to severe pain in opioid-treated patients with osteoarthritis or low back pain

The journal of pain, 2012-04, Vol.13 (4), p.S84-S84

2012

Volltextzugriff (PDF)

P.6.c.010 Abuse liability of intravenous lisdexamfetamine dimesylate

European neuropsychopharmacology, 2008, Vol.18, p.S537-S538

2008

Volltextzugriff (PDF)

Safety and Efficacy of Bupivacaine HCl Collagen-Matrix Implant (INL-001) in Open Inguinal Hernia Repair: Results from Two Randomized Controlled Trials

Advances in therapy, 2019-01, Vol.36 (1), p.200-216

2019

Volltextzugriff (PDF)

Effect size comparison of ketorolac nasal spray and commonly prescribed oral combination opioids for pain relief after third molar extraction surgery

Postgraduate medicine, 2016-01, Vol.128 (1), p.12-17

2016

Volltextzugriff (PDF)

The natural history of prescription opioid abuse: A pilot study exploring change in routes of administration and motivation for changes

Journal of opioid management, 2018-11, Vol.14 (6), p.397-405

2018

Volltextzugriff (PDF)

Clinical relevance of the pharmacokinetic characteristics of an abuse-deterrent, extended-release, injection-molded morphine tablet

Journal of opioid management, 2017-03, Vol.13 (2), p.111-124

2017

Volltextzugriff (PDF)

Modafinil for Excessive Sleepiness Associated with Shift-Work Sleep Disorder

The New England journal of medicine, 2005-08, Vol.353 (5), p.476-486

2005

Volltextzugriff (PDF)

Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss

Current medical research and opinion, 2006-01, Vol.22 (1), p.159-167

2006

Volltextzugriff (PDF)

(941): A new tool for assessing the functional and emotional impact of pain and effects of treatment: The goal attainment scale

The journal of pain, 2006-04, Vol.7 (4), p.S85-S85

2006

Volltextzugriff (PDF)

731

The journal of pain, 2006-04, Vol.7 (4), p.S35

2006

Volltextzugriff (PDF)

(731): Successful dose finding with fentanyl effervescent buccal tablets: Combined results of open-label titration

The journal of pain, 2006-04, Vol.7 (4), p.S35-S35

2006

Volltextzugriff (PDF)

941

The journal of pain, 2006-04, Vol.7 (4), p.S85

2006

Volltextzugriff (PDF)

Finding an effective dose of fentanyl effervescent buccal tablets: Combined results of open-label titration

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.18521-18521

2006

Volltextzugriff (PDF)

Long-term tolerability of fentanyl effervescent buccal tablets: Interim analysis in patients with cancer-related breakthrough pain

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.8567-8567

2006

Volltextzugriff (PDF)

Fulminant multiple sclerosis

American journal of neuroradiology : AJNR, 1992-11, Vol.13 (6), p.1547-1551

1992

Volltextzugriff (PDF)

(732): Patients’ experience with fentanyl effervescent buccal tablets: Interim analysis of a long-term, multicenter, open-label study in cancer-related breakthrough pain

The journal of pain, 2006-04, Vol.7 (4), p.S35-S35

2006

Volltextzugriff (PDF)

732

The journal of pain, 2006-04, Vol.7 (4), p.S35

2006

Volltextzugriff (PDF)

(804): Open-label study of fentanyl effervescent buccal tablets in patients with noncancer pain and breakthrough pain: Patient preference assessment

The journal of pain, 2006-04, Vol.7 (4), p.S52-S52

2006

Volltextzugriff (PDF)

804

The journal of pain, 2006-04, Vol.7 (4), p.S52

2006

Volltextzugriff (PDF)

Motor changes in presymptomatic Huntington disease gene carriers

Archives of neurology (Chicago), 1996-06, Vol.53 (6), p.487-492

1996

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(54)
Tagungsberichte
(1)

Sprache

Englisch
(50)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

(239) Bioequivalence of abuse-deterrent, immediate-release (ADIR) oxycodone compared with IR oxycodone without abuse-deterrent properties

(430) Bioequivalence and food effect of a novel, abuse-deterrent (AD), extended-release (ER) morphine product candidate compared with a currently available non-AD, ER morphine product

(237) Novel design to evaluate the efficacy and safety of an abuse-deterrent, extended-release oxycodone product candidate in patients with moderate-to-severe chronic low back pain

(238) The relationship between the pharmacokinetics of morphine abuse-deterrent, extended-release, injection-molded tablets and pharmacodynamic outcomes in oral and intranasal human abuse potential studies

Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome

Efficacy and tolerability of hydrocodone extended-release tablets for the treatment of moderate to severe pain in opioid-treated patients with osteoarthritis or low back pain

P.6.c.010 Abuse liability of intravenous lisdexamfetamine dimesylate

Safety and Efficacy of Bupivacaine HCl Collagen-Matrix Implant (INL-001) in Open Inguinal Hernia Repair: Results from Two Randomized Controlled Trials

Effect size comparison of ketorolac nasal spray and commonly prescribed oral combination opioids for pain relief after third molar extraction surgery

The natural history of prescription opioid abuse: A pilot study exploring change in routes of administration and motivation for changes

Clinical relevance of the pharmacokinetic characteristics of an abuse-deterrent, extended-release, injection-molded morphine tablet

Modafinil for Excessive Sleepiness Associated with Shift-Work Sleep Disorder

Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss

(941): A new tool for assessing the functional and emotional impact of pain and effects of treatment: The goal attainment scale

731

(731): Successful dose finding with fentanyl effervescent buccal tablets: Combined results of open-label titration

941

Finding an effective dose of fentanyl effervescent buccal tablets: Combined results of open-label titration

Long-term tolerability of fentanyl effervescent buccal tablets: Interim analysis in patients with cancer-related breakthrough pain

Fulminant multiple sclerosis

(732): Patients’ experience with fentanyl effervescent buccal tablets: Interim analysis of a long-term, multicenter, open-label study in cancer-related breakthrough pain

732

(804): Open-label study of fentanyl effervescent buccal tablets in patients with noncancer pain and breakthrough pain: Patient preference assessment

804

Motor changes in presymptomatic Huntington disease gene carriers

Suchergebnisse filtern